Company Overview and News


Add AVGR
to your dashboard

Headline News

Your Daily Pharma Scoop: A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tumbles

2017-11-16 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (381-1)

Avinger's (AVGR) CEO Jeff Soinski on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good day, ladies and gentlemen, and welcome to the Avinger Third Quarter 2017 Earnings Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call is being recorded. (62-0)

Your Daily Pharma Scoop: Nektar's Potential, Axovant Finally Fails, PTCT AdComm Tomorrow

2017-09-27 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (90-4)

Medical Equipment Stocks on Investors' Radar -- Align Technology, Masimo, Corindus Vascular Robotics, and Avinger

2017-09-21 prnewswire
If you want a Stock Review on ALGN, MASI, CVRS, or AVGR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Wednesday, September 20, 2017, US markets saw five out of nine sectors finishing the day in green and 4 in red. Major US indices were also mixed at the close of yesterday's session. The NASDAQ Composite ended the day at 6,456.04, down 0. (116-1)

Today's Research Report Coverage on Medical Equipment Stocks -- Avinger, ViewRay, EnteroMedics, and Nevro

2017-08-18 prnewswire
If you want a Stock Review on AVGR, VRAY, ETRM, or NVRO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The Medical Appliances and Equipment space primarily offers equipment and devices, which are designed for diagnosis, monitoring, and treatment of patients in healthcare systems worldwide. Firms in this industry research, develop, and manufacture primarily surgical, diagnostic, and orthopedic instruments. (0-1)

Avinger's (AVGR) CEO Jeff Soinski on Q2 2017 Results - Earnings Call Transcript

2017-08-09 seekingalpha
Good day, Ladies and Gentlemen, and welcome to the Second Quarter 2017 Avinger Inc. Earnings Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instruction will follow at that time. [Operator Instructions] As a reminder, this call maybe recorded. (0-1)

Avinger To Announce Second Quarter 2017 Results On August 8, 2017

2017-07-27 devicespace
REDWOOD CITY, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release its financial results for the second quarter of 2017 after the close of trading on Tuesday, August 8, 2017. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of a Securities Action on Behalf of Shareholders of Avinger, Inc. - AVGR

2017-07-14 accesswire
NEW YORK, NY / ACCESSWIRE / July 14, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: (0-1)

AVGR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Securities Action Involving Avinger, Inc. (AVGR)

2017-07-13 accesswire
NEW YORK, NY / ACCESSWIRE / July 13, 2017 / The Law Offices of Vincent Wong announce that a securities action has been commenced on behalf of investors who purchased Avinger, Inc. ("Avinger") (NASDAQ: AVGR) securities pursuant and/or traceable to the Company's Stock Offering on or about January 30, 2015.

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Encourages Investors with Losses to Contact the Firm

2017-07-12 accesswire
LOS ANGELES, CA / ACCESSWIRE / July 12, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Avinger, Inc. ("Avinger" or the "Company") (NASDAQ: AVGR) for possible violations of federal securities laws. Investors who purchased or otherwise acquired Avinger shares pursuant and/or traceable to its initial public offering ("IPO") on January 30, 2015, should contact the firm.

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Avinger, Inc. (AVGR) & Lead Plaintiff Deadline: September 5, 2017

2017-07-07 prnewswire
NEW YORK, July 7, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Avinger, Inc. ("Avinger" or the "Company") (NASDAQ: AVGR) and certain of its officers, on behalf of shareholders who purchased Avinger common stock pursuant to the Registration Statement and Prospectus issued in connection with Avinger's initial public offering ("IPO") on or around January 30, 2015.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of a Securities Action on Behalf of Shareholders of Avinger, Inc. - AVGR

2017-07-07 accesswire
NEW YORK, NY / ACCESSWIRE / July 7, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

Avinger's Pantheris shows long-term treatment benefit in atherectomy; shares up 26% - Avinger (NASDAQ:AVGR) | Seeking Alpha

2017-07-06 seekingalpha
Nano cap Avinger (AVGR +25.7%) heads north on a 7x surge in volume in response to positive 24-month data from the VISION study assessing the safety and effectiveness of its Pantheris system in performing directional atherectomy while allowing the physician to use real-time intravascular imaging to aid in the removal of plaque from leg arteries.

The Klein Law Firm Reminds Investors of a Securities Action Filed on Behalf of Avinger, Inc. Shareholders (AVGR)

2017-06-28 accesswire
NEW YORK, NY / ACCESSWIRE / June 28, 2017 / The Klein Law Firm announces that securities complaint has been filed on behalf of shareholders of Avinger, Inc. (NASDAQ: AVGR) who purchased shares pursuant and/or traceable to the Company's Stock Offering on or about January 30, 2015.

AVINGER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Avinger, Inc. to Contact the Firm

2017-06-26 accesswire
NEW YORK, NY / ACCESSWIRE / June 26, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Avinger, Inc. ("Avinger" or the "Company") (NASDAQ: AVGR) of the filing of a securities lawsuit against the Company.

Stock Research Report

Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease, or PAD. Patients with PAD have a build-up of plaque in the arteries that supply blood to areas away from the heart, particularly the pelvis and legs. The company's mission is to dramatically improve the treatment of vascular disease through the introduction of products based on its Lumivascular platform, the only intravascular image-guided system available in this market. The company manufacture and sell a suite of products in the United States and select international markets. The company's current products include its Lightbox imaging console, as well as its Wildcat, Kittycat 2, and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion, or CTO, and Pantheris, its image-guided atherectomy ...

Click for full article
CUSIP: 053734109